Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-004091
Filing Date
2017-05-10
Accepted
2017-05-10 13:01:16
Documents
49
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ecyt-20170331x10q.htm 10-Q 946717
2 EX-10.1 ecyt-20170331ex10174ac25.htm EX-10.1 175449
3 EX-10.2 ecyt-20170331ex102c392bd.htm EX-10.2 18174
4 EX-10.3 ecyt-20170331ex1038ead34.htm EX-10.3 285799
5 EX-31.1 ecyt-20170331ex31154270e.htm EX-31.1 20032
6 EX-31.2 ecyt-20170331ex312c5f55a.htm EX-31.2 18225
7 EX-32.1 ecyt-20170331ex321376cce.htm EX-32.1 15451
  Complete submission text file 0001558370-17-004091.txt   4441003

Data Files

Seq Description Document Type Size
8 EX-101.INS ecyt-20170331.xml EX-101.INS 859395
9 EX-101.SCH ecyt-20170331.xsd EX-101.SCH 22548
10 EX-101.CAL ecyt-20170331_cal.xml EX-101.CAL 27498
11 EX-101.DEF ecyt-20170331_def.xml EX-101.DEF 100906
12 EX-101.LAB ecyt-20170331_lab.xml EX-101.LAB 261069
13 EX-101.PRE ecyt-20170331_pre.xml EX-101.PRE 213711
Mailing Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906
Business Address 3000 KENT AVE STE A1-100 WEST LAFAYETTE IN 47906 7654637175
ENDOCYTE INC (Filer) CIK: 0001235007 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35050 | Film No.: 17829439
SIC: 2834 Pharmaceutical Preparations